2025.10. 20 本文字数：1211，阅读时长大约2分钟 作者 | 第一财经 钱童心 近期，首款国产九价HPV（人乳头瘤病毒）疫苗开放预约渠道，在全国陆续开始接种，2针剂接种范 围扩大至9至17岁。此前，默沙东的九价HPV疫苗和GSK的二价HPV疫苗也都已经扩龄。 截至目前，国内共有6款HPV疫苗获批，进口和国产分别有三款。此前，我国HPV疫苗市场主要由进 口产品主导，默沙东的四价和九价"佳达修"系列以及GSK的二价"希瑞适"占据了90%以上的市场份 额。但近年来，随着万泰生物等公司的多款国产HPV疫苗陆续上市，也推动了价格的进一步下降， 提升了疫苗的可及性。 值得关注的是，上个月的国新办发布会上消息称，今年国家将推出面向适龄女生的HPV疫苗接种服 务，并将HPV疫苗纳入国家免疫规划，保护女性的健康。此举标志着HPV疫苗有望进入普惠时代， 有助于实现"消除宫颈癌"战略目标。 国际经验显示，国家免疫规划是提升疫苗接种率的关键。全球已有149个国家将HPV疫苗纳入规划， 平均接种率约60%：加拿大、澳大利亚、英国2023年接种率分别达86%、71%、68%。 以澳大利亚为例，该国作为全球首个将HPV疫苗纳入 ...

Core Insights - The first domestically produced nine-valent HPV vaccine has opened for appointments and is being administered nationwide, with the vaccination range expanded to ages 9 to 17 [1] - Currently, there are six approved HPV vaccines in China, with three being imported and three domestically produced, previously dominated by imported products [1] - The inclusion of HPV vaccines in the national immunization program is expected to enhance accessibility and contribute to the goal of "eliminating cervical cancer" [1][2] Group 1 - The domestic HPV vaccine market is seeing increased competition, leading to a decrease in prices and improved accessibility for the population [1] - As of now, 149 countries have included HPV vaccines in their national immunization programs, with an average vaccination rate of about 60% [1] - Countries like Canada, Australia, and the UK have achieved high vaccination rates of 86%, 71%, and 68% respectively in 2023 [1] Group 2 - Australia's multi-tiered service system for HPV vaccination includes school-based programs and community clinics, which could serve as a model for China's implementation [2] - Experts predict that the rollout of free HPV vaccines in China will be phased, initially targeting key populations before expanding to a broader audience [2] - The focus on university students as a key demographic for HPV prevention is based on public health strategies, emphasizing the high return on investment for health measures during this stage [2] Group 3 - The concept of "gender-neutral vaccination" is gaining traction, with studies indicating that widespread vaccination can significantly reduce cervical cancer cases by 90% [3] - Vaccination of both males and females can establish strong herd immunity, reducing the transmission of HPV and protecting the entire population [3] - The latest guidelines advocate for the importance of HPV vaccination for both genders, highlighting the broader health benefits of such an approach [3]

如今，"男女共防"已经成为中国最新权威指南倡导的HPV预防接种重要策略。据了解，HPV疫苗的广泛 接种可将子宫颈癌发病率降低90%以上，而男性人群接种HPV疫苗不仅可以直接降低男性人群中HPV相 关良恶性肿瘤疾病负担，也可以间接保护其伴侣，通过群体免疫效应减少病毒传播。 如何科学高效预防HPV感染？专家："男女共防"是成功关键 中新网上海10月19日电 (记者 陈静)预防人乳头瘤病毒(HPV)感染是近年来社会关注的健康话题。"我们 将大学生群体视为HPV预防的重点人群，是出于科学的公共卫生策略考量。"上海的妇科专家丛青教授 19日接受记者采访时表示，在大学阶段积极采取HPV预防措施，对大学生来说是一项投入产出比极高的 健康投资。 对于如何科学高效地预防HPV感染，丛青教授指出，"男女共防"是成功的关键。她指出，当男性和女性 都大规模接种HPV疫苗后，就能在人群中建立起强大的"群体免疫"，减少病毒在人群中的传播，从而保 护群体中的每一个人。 并肩共防"健康校园·篮球挑战赛"全国总决赛19日在上海交通大学霍英东体育馆举行。此次赛事活动将 激烈的篮球竞技与前沿的健康科普相融合，旨在提升男女大学生对HPV预防的认知。 ...